Patent · US Active

Oligonucleotides comprising modified nucleosides

US11578330B2 · kind B2 · utility

0Cited by

7References

21Claims

0Family size

Assignee

SomaLogic Operating Co., Inc. · US

Inventors

Jeff Carter · Boulder, US
Bharat Nathu Gawande · Boulder, US
Nebojsa Janjic · Boulder, US
Daniel J. Schneider · Arvada, US

Key dates

Filing date	Dec 18, 2020
Grant date	Feb 14, 2023
Priority date	—
Expiry date	Aug 31, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2330/31
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Polynucleotides, such as aptamers, comprising at least first one 5-position modified pyrimidine and at least one second 5-position modified pyrimidine are provided, wherein the first and second 5-position modified pyrimidines are different. Methods of selecting and using such polynucleotides, such as aptamers, are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.